DiaMedica Inc

Nanocopoeia is a specialty research company based in Saint Paul, Minnesota, founded in 2001 and initially focused on medical devices and advanced nano-scale coating processes. With a recent restructuring, the company is now dedicated to enhancing oral-solid drug development through innovative technologies that address low solubility and bioavailability challenges. Led by an experienced executive team, Nanocopoeia aims to create valuable drug products that improve patient safety, compliance, and effectiveness. The company actively seeks partnerships and collaboration to build long-term value in the pharmaceutical industry, emphasizing a commitment to teamwork and innovation. Generated from the website

DiaMedica Therapeutics Inc., based in Hopkins, MN, is dedicated to developing innovative therapies aimed at improving the lives of individuals facing serious vascular diseases, with a primary focus on preeclampsia and acute ischemic stroke. The company's approach centers on enhancing blood flow to ischemic tissues, thereby advancing patient outcomes in these critical areas. With a significant unmet need for effective treatment options, DiaMedica is investigating its investigational drug candidate DM199, which aims to restore normal levels of the KLK1 protein to help regulate blood flow and maintain vascular homeostasis. The company is addressing alarming trends in maternal mortality related to preeclampsia and the urgent requirements for stroke patients, contributing meaningfully to these challenging health issues. Generated from the website

Amerilab Technologies Inc, based in Minneapolis, is a trusted full turnkey manufacturer specializing in customized effervescent tablets and powders, as well as non-effervescent powders. With over 25 years of industry experience, Amerilab is known for its expertise in developing, producing, and packaging custom products for clients, setting the standard for contract manufacturing excellence. Generated from their website's infomation